Accessibility Menu
TFF Pharmaceuticals logo

TFF Pharmaceuticals

(NASDAQ) TFFP

This security has been delisted. This page is retained for historical reference.

TFFP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

TFFP Financials

Key Financial Metrics (TTM)

Gross Margin

31.53%

Operating Margin

-2983.45%

Net Income Margin

-2894.68%

Return on Equity

-130.94%

Return on Capital

-226.13%

Return on Assets

-176.62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.37M

Operating Income

-$19.02M

EBITDA

-$18.10M

Operating Cash Flow

-$12.59M

Capital Expenditure

-$46.39K

Free Cash Flow

-$12.64M

Cash & ST Invst.

$2.61M

Total Debt

$52.40K

TFF Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$193.39K

N/A

Gross Profit

$193.39K

+254.6%

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

19

N/A

Net Income

-$3.54M

+19.6%

EBITDA

-$3.44M

+19.7%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$2.61M

-73.2%

Total Debt

$52.40K

-61.2%

Accounts Receivable

$309.83K

-14.3%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$104.81K

-36.7%

Return on Assets

-1.77%

N/A

Return on Invested Capital

-2.28%

N/A

Free Cash Flow

-$1.98M

+34.3%

Operating Cash Flow

-$1.98M

+34.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VIRIVirios Therapeutics, Inc.
$0.16+12.40%
LFLYLeafly Holdings, Inc.
$37.00+0.00%
BLPHBellerophon Therapeutics, Inc.
$0.01-36.84%
PHIOPhio Pharmaceuticals Corp.
$1.02-1.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
PATHUiPath
$11.68-0.01%
INTCIntel
$109.84-0.02%
ONDSOndas
$7.26-0.05%
NOKNokia
$12.44-0.04%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.